Experience. Commitment. Results.
Ra Pharmaceuticals, Inc. (RARX) related to its sale to UCB S.A. Under the terms of the agreement, each share of RARX common stock will be converted into the right to receive $48.00 in cash per share of RARX common stock owned. The transaction value is expected to be approximately $2.1 billion.
Astea International, Inc. (ATEA) related to sale to IFS Americas, Inc. Under the terms of the transaction, each share of Astea common stock will be converted into the right to receive $12.00 in cash for each share of Astea common stock owned.
Dova Pharmaceuticals, Inc (DOVA) related to its sale to Swedish Orphan Biovirtum AB. Dova shareholders have the right to receive $27.50 in cash per Dova common stock owned and one Contingent Value Right of $1.50 per share of Dova common stock owned.
Greenland Acquisition Corporation (GLAC) related to its combination with Zhongchai Holding. Pursuant to the terms of the Agreement, Greenland will acquire 100% of the issued and outstanding capital stock of Zhongchai Holding in exchange for the issuance of 7,500,000 Greenland shares to the Zhongchai Equity Holder. As a result of the Proposed Transaction, Greenland’s current … Read more
Allergan plc (AGN) related to its sale to AbbVie Inc. Under the terms of the Merger Agreement, Allergan’s stockholders will receive $120.30 in cash and 0.8660 AbbVie shares for each share of Allergan common stock they own.
Restoration Robotics, Inc (HAIR) related to its combination with Venus Concept Ltd. Pursuant to the terms of the Merger Agreement, each share of Venus Concept will be converted into the right to receive 8.6506 shares of Restoration Robotics common stock. In result of the transaction, Restoration Robotics and Venus Concept shareholders will own approximately 15% … Read more
Progenics Pharmaceuticals, Inc. (PGNX) related to its sale to Lantheus Holdings, Inc. Under the terms of the transaction, each share of Progenics common stock issued will automatically be converted into the right to receive 0.2502 of a share of Lantheus common stock for each share of Progenics common stock.
Roan Resources, Inc (ROAN) related to its sale to Citizen Energy Operating, LLC. Under the terms of the transaction, each share of Roan common stock will be converted into the right to receive $1.52 in cash for each share of Roan common stock owned.
Charden Heathcare Acquisition Corp. (CHAC) related to its combination with BiomX Ltd. Pursuant to the terms of the Merger Agreement, BiomX’s securityholders will receive an aggregate of 16,625,000 Chardan shares. As a result of the Proposed Transaction, Chardan’s public stockholders will only own approximately 20% of Chardan’s stock.
Empire Resort, Inc (NYNY) related to its sale to Kien Huat Realty III Limited and Genting Malaysia Berhad. Under the terms of the transaction, each share of NYNY common stock will be converted into the right to receive $9.74 in cash for each share of NYNY common stock owned.